These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33391183)

  • 1. Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms.
    Fujisawa Y; Kitaoka T; Ono H; Nakashima S; Ozono K; Ogata T
    Front Endocrinol (Lausanne); 2020; 11():590455. PubMed ID: 33391183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA.
    Scott LJ
    BioDrugs; 2016 Feb; 30(1):41-8. PubMed ID: 26832358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial.
    Whyte MP; Simmons JH; Moseley S; Fujita KP; Bishop N; Salman NJ; Taylor J; Phillips D; McGinn M; McAlister WH
    Lancet Diabetes Endocrinol; 2019 Feb; 7(2):93-105. PubMed ID: 30558909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.
    Kishnani PS; Rush ET; Arundel P; Bishop N; Dahir K; Fraser W; Harmatz P; Linglart A; Munns CF; Nunes ME; Saal HM; Seefried L; Ozono K
    Mol Genet Metab; 2017 Sep; 122(1-2):4-17. PubMed ID: 28888853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trial.
    Kitaoka T; Tajima T; Nagasaki K; Kikuchi T; Yamamoto K; Michigami T; Okada S; Fujiwara I; Kokaji M; Mochizuki H; Ogata T; Tatebayashi K; Watanabe A; Yatsuga S; Kubota T; Ozono K
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):10-19. PubMed ID: 28374482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa.
    Kishnani PS; Del Angel G; Zhou S; Rush ET
    Mol Genet Metab; 2021 May; 133(1):113-121. PubMed ID: 33814268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.
    Whyte MP; Rockman-Greenberg C; Ozono K; Riese R; Moseley S; Melian A; Thompson DD; Bishop N; Hofmann C
    J Clin Endocrinol Metab; 2016 Jan; 101(1):334-42. PubMed ID: 26529632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia.
    Bowden SA; Adler BH
    Osteoporos Int; 2018 Feb; 29(2):511-515. PubMed ID: 29046930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia.
    Pan WJ; Pradhan R; Pelto R; Seefried L
    J Clin Pharmacol; 2021 Oct; 61(10):1334-1343. PubMed ID: 33822385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
    Scott LJ
    Drugs; 2016 Feb; 76(2):255-62. PubMed ID: 26744272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
    Kishnani PS; Rockman-Greenberg C; Rauch F; Bhatti MT; Moseley S; Denker AE; Watsky E; Whyte MP
    Bone; 2019 Apr; 121():149-162. PubMed ID: 30576866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels.
    Koyama H; Yasuda S; Kakoi S; Ohata Y; Shimizu Y; Hasegawa C; Hayakawa A; Akiyama T; Yagi T; Aotani D; Imaeda K; Ozono K; Kataoka H; Tanaka T
    Intern Med; 2020 Mar; 59(6):811-815. PubMed ID: 31787692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of asfotase alfa in patients with hypophosphatasia: A systematic review.
    Shirinezhad A; Esmaeili S; Azarboo A; Tavakoli Y; Hoveidaei AH; Zareshahi N; Ghaseminejad-Raeini A
    Bone; 2024 Nov; 188():117219. PubMed ID: 39089608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two-year follow-up of asfotase alfa replacement in a patient with hypophosphatasia: clinical, biochemical, and radiological evaluation.
    Reis FS; Gomes DC; Arantes HP; Lazaretti-Castro M
    Arch Endocrinol Metab; 2021 May; 64(5):623-629. PubMed ID: 34033304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme replacement therapy for congenital hypophosphatasia allows for surgical treatment of related complex craniosynostosis: a case series.
    Kosnik-Infinger L; Gendron C; Gordon CB; Pan BS; van Aalst JA; Vogel TW
    Neurosurg Focus; 2015 May; 38(5):E10. PubMed ID: 25929963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asfotase alfa therapy for children with hypophosphatasia.
    Whyte MP; Madson KL; Phillips D; Reeves AL; McAlister WH; Yakimoski A; Mack KE; Hamilton K; Kagan K; Fujita KP; Thompson DD; Moseley S; Odrljin T; Rockman-Greenberg C
    JCI Insight; 2016 Jun; 1(9):e85971. PubMed ID: 27699270
    [No Abstract]   [Full Text] [Related]  

  • 17. Status Epilepticus due to Asfotase Alfa Interruption in Perinatal Severe Hypophosphatasia.
    Ogawa E; Shimura K; Yoshihashi H; Miyama S
    Pediatr Neurol; 2022 May; 130():4-6. PubMed ID: 35303588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa.
    Seefried L; Rak D; Petryk A; Genest F
    Osteoporos Int; 2021 Dec; 32(12):2505-2513. PubMed ID: 34215909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spurious testosterone laboratory results in a patient taking synthetic alkaline phosphatase (asfotase alfa).
    Sofronescu AG; Ross M; Rush E; Goldner W
    Clin Biochem; 2018 Aug; 58():118-121. PubMed ID: 29709501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asfotase alfa: enzyme replacement for the treatment of bone disease in hypophosphatasia.
    Hofmann C; Seefried L; Jakob F
    Drugs Today (Barc); 2016 May; 52(5):271-85. PubMed ID: 27376160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.